Biologics Center 510(k) Reviews Show Improvement In Early Fiscal ’03 – CBER

Increased willingness by Center for Biologics Evaluation & Research reviewers to participate in interactive reviews could help reduce review cycles and times for devices and in vitro diagnostics at the biologics center, attorney Jonathan Kahan suggested